$270 Million is the total value of Virtus ETF Advisers LLC's 441 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALLK | Exit | ALLAKOS INC | $0 | – | -1,902 | -100.0% | -0.01% | – |
| ALGS | Exit | ALIGOS THERAPEUTICS INC | $0 | – | -13,420 | -100.0% | -0.01% | – |
| ANNX | Exit | ANNEXON INC | $0 | – | -11,398 | -100.0% | -0.01% | – |
| MEIP | Exit | MEI PHARMA INC | $0 | – | -64,614 | -100.0% | -0.02% | – |
| BCAB | Exit | BIOATLA INC | $0 | – | -7,475 | -100.0% | -0.02% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INC | $0 | – | -65,149 | -100.0% | -0.02% | – |
| GRTS | Exit | GRITSTONE BIO INC | $0 | – | -13,538 | -100.0% | -0.02% | – |
| DTIL | Exit | PRECISION BIOSCIENCES INC | $0 | – | -18,963 | -100.0% | -0.03% | – |
| GRCL | Exit | GRACELL BIOTECHNOLOGIES INCsponsored ads | $0 | – | -24,728 | -100.0% | -0.03% | – |
| SELB | Exit | SELECTA BIOSCIENCES INC | $0 | – | -49,234 | -100.0% | -0.03% | – |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -25,634 | -100.0% | -0.03% | – |
| RUBY | Exit | RUBIUS THERAPEUTICS INC | $0 | – | -12,052 | -100.0% | -0.03% | – |
| CUE | Exit | CUE BIOPHARMA INC | $0 | – | -14,281 | -100.0% | -0.03% | – |
| ORIC | Exit | ORIC PHARMACEUTICALS INC | $0 | – | -12,914 | -100.0% | -0.03% | – |
| PASG | Exit | PASSAGE BIO INC | $0 | – | -23,317 | -100.0% | -0.03% | – |
| EVLO | Exit | EVELO BIOSCIENCES INC | $0 | – | -21,013 | -100.0% | -0.03% | – |
| PLRX | Exit | PLIANT THERAPEUTICS INC | $0 | – | -10,224 | -100.0% | -0.03% | – |
| ALVR | Exit | ALLOVIR INC | $0 | – | -10,463 | -100.0% | -0.03% | – |
| TSHA | Exit | TAYSHA GENE THERAPIES INC | $0 | – | -10,878 | -100.0% | -0.03% | – |
| OLMA | Exit | OLEMA PHARMACEUTICALS INC | $0 | – | -17,135 | -100.0% | -0.03% | – |
| VOR | Exit | VOR BIOPHARMA INC | $0 | – | -12,572 | -100.0% | -0.03% | – |
| CVM | Exit | CEL-SCI CORP | $0 | – | -19,631 | -100.0% | -0.03% | – |
| GRPH | Exit | GRAPHITE BIO INC | $0 | – | -14,964 | -100.0% | -0.03% | – |
| STTK | Exit | SHATTUCK LABS INC | $0 | – | -18,546 | -100.0% | -0.04% | – |
| SRRK | Exit | SCHOLAR ROCK HLDG CORP | $0 | – | -6,212 | -100.0% | -0.04% | – |
| EPIX | Exit | ESSA PHARMA INC | $0 | – | -12,885 | -100.0% | -0.04% | – |
| LXRX | Exit | LEXICON PHARMACEUTICALS INC | $0 | – | -39,262 | -100.0% | -0.04% | – |
| CRIS | Exit | CURIS INC | $0 | – | -34,848 | -100.0% | -0.04% | – |
| CRTX | Exit | CORTEXYME INC | $0 | – | -13,657 | -100.0% | -0.04% | – |
| ZIOP | Exit | ALAUNOS THERAPEUTICS INC | $0 | – | -131,413 | -100.0% | -0.04% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -9,556 | -100.0% | -0.04% | – |
| KRON | Exit | KRONOS BIO INC | $0 | – | -11,844 | -100.0% | -0.04% | – |
| AMTI | Exit | APPLIED MOLECULAR TRANS INC | $0 | – | -11,621 | -100.0% | -0.04% | – |
| PRAX | Exit | PRAXIS PRECISION MEDICINES I | $0 | – | -8,515 | -100.0% | -0.04% | – |
| STRO | Exit | SUTRO BIOPHARMA INC | $0 | – | -10,670 | -100.0% | -0.04% | – |
| ADAP | Exit | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $0 | – | -44,300 | -100.0% | -0.04% | – |
| VSTM | Exit | VERASTEM INC | $0 | – | -68,924 | -100.0% | -0.04% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -32,708 | -100.0% | -0.04% | – |
| KNTE | Exit | KINNATE BIOPHARMA INC | $0 | – | -9,184 | -100.0% | -0.05% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -22,945 | -100.0% | -0.05% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -3,893 | -100.0% | -0.05% | – |
| FMTX | Exit | FORMA THERAPEUTICS HLDGS INC | $0 | – | -11,234 | -100.0% | -0.05% | – |
| FIXX | Exit | HOMOLOGY MEDICINES INC | $0 | – | -35,487 | -100.0% | -0.05% | – |
| HGEN | Exit | HUMANIGEN INC | $0 | – | -36,572 | -100.0% | -0.05% | – |
| VBIV | Exit | VBI VACCINES INC CDA | $0 | – | -69,220 | -100.0% | -0.05% | – |
| AUTL | Exit | AUTOLUS THERAPEUTICS PLCspon ads | $0 | – | -27,536 | -100.0% | -0.05% | – |
| GTHX | Exit | G1 THERAPEUTICS INC | $0 | – | -15,188 | -100.0% | -0.05% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -57,437 | -100.0% | -0.05% | – |
| FDMT | Exit | 4D MOLECULAR THERAPEUTICS IN | $0 | – | -7,683 | -100.0% | -0.05% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -25,976 | -100.0% | -0.05% | – |
| CGEN | Exit | COMPUGEN LTDord | $0 | – | -37,909 | -100.0% | -0.06% | – |
| ACIU | Exit | AC IMMUNE SA | $0 | – | -31,014 | -100.0% | -0.06% | – |
| CNTA | Exit | CENTESSA PHARMACEUTICALS PLCsponsored ads | $0 | – | -13,969 | -100.0% | -0.06% | – |
| Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -15,039 | -100.0% | -0.06% | – | |
| COGT | Exit | COGENT BIOSCIENCES INC | $0 | – | -19,452 | -100.0% | -0.06% | – |
| BKLN | Exit | INVESCO EXCH TRADED FD TR IIsr ln etf | $0 | – | -6,820 | -100.0% | -0.07% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -11,784 | -100.0% | -0.08% | – |
| RYTM | Exit | RHYTHM PHARMACEUTICALS INC | $0 | – | -16,317 | -100.0% | -0.08% | – |
| PRVB | Exit | PROVENTION BIO INC | $0 | – | -26,467 | -100.0% | -0.09% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -40,607 | -100.0% | -0.09% | – |
| Exit | 2SEVENTY BIO INC | $0 | – | -13,134 | -100.0% | -0.10% | – | |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -9,496 | -100.0% | -0.10% | – |
| YMAB | Exit | Y-MABS THERAPEUTICS INC | $0 | – | -23,646 | -100.0% | -0.13% | – |
| ADCT | Exit | ADC THERAPEUTICS SA | $0 | – | -19,193 | -100.0% | -0.13% | – |
| SUNS | Exit | SLR SENIOR INVESTMENT CORP | $0 | – | -23,152 | -100.0% | -0.15% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -3,575 | -100.0% | -0.19% | – |
| BRW | Exit | SABA CAPITAL INCOME & OPRNTshares | $0 | – | -102,011 | -100.0% | -0.21% | – |
| BPMP | Exit | BP MIDSTREAM PARTNERS LPunit ltd ptnr | $0 | – | -104,162 | -100.0% | -0.79% | – |
| Exit | FALCON MINERALS CORP | $0 | – | -344,566 | -100.0% | -1.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| REGENERON PHARMACEUTICALS | 31 | Q3 2023 | 1.8% |
| INCYTE CORP | 31 | Q3 2023 | 2.1% |
| ENANTA PHARMACEUTICALS INC | 31 | Q3 2023 | 2.2% |
| EXELIXIS INC | 31 | Q3 2023 | 1.8% |
| VANDA PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| IRONWOOD PHARMACEUTICALS INC | 31 | Q3 2023 | 2.0% |
| LIGAND PHARMACEUTICALS INC | 31 | Q3 2023 | 1.5% |
| GILEAD SCIENCES INC | 31 | Q3 2023 | 1.6% |
| HALOZYME THERAPEUTICS INC | 31 | Q3 2023 | 1.7% |
View Virtus ETF Advisers LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-15 |
| 13F-HR | 2023-11-07 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Virtus ETF Advisers LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.